Francis, J.E.; Skakic, I.; Dekiwadia, C.; Shukla, R.; Taki, A.C.; Walduck, A.; Smooker, P.M.
Solid Lipid Nanoparticle Carrier Platform Containing Synthetic TLR4 Agonist Mediates Non-Viral DNA Vaccine Delivery. Vaccines 2020, 8, 551.
https://doi.org/10.3390/vaccines8030551
AMA Style
Francis JE, Skakic I, Dekiwadia C, Shukla R, Taki AC, Walduck A, Smooker PM.
Solid Lipid Nanoparticle Carrier Platform Containing Synthetic TLR4 Agonist Mediates Non-Viral DNA Vaccine Delivery. Vaccines. 2020; 8(3):551.
https://doi.org/10.3390/vaccines8030551
Chicago/Turabian Style
Francis, Jasmine E., Ivana Skakic, Chaitali Dekiwadia, Ravi Shukla, Aya C. Taki, Anna Walduck, and Peter M. Smooker.
2020. "Solid Lipid Nanoparticle Carrier Platform Containing Synthetic TLR4 Agonist Mediates Non-Viral DNA Vaccine Delivery" Vaccines 8, no. 3: 551.
https://doi.org/10.3390/vaccines8030551
APA Style
Francis, J. E., Skakic, I., Dekiwadia, C., Shukla, R., Taki, A. C., Walduck, A., & Smooker, P. M.
(2020). Solid Lipid Nanoparticle Carrier Platform Containing Synthetic TLR4 Agonist Mediates Non-Viral DNA Vaccine Delivery. Vaccines, 8(3), 551.
https://doi.org/10.3390/vaccines8030551